Annual Current Assets
$95.96 M
+$57.69 M+150.72%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual total current assets is $95.96 million, with the most recent change of +$57.69 million (+150.72%) on December 31, 2023.
- During the last 3 years, VYNE annual current assets has risen by +$8.70 million (+9.97%).
- VYNE annual current assets is now -31.21% below its all-time high of $139.50 million, reached on December 31, 2018.
Performance
VYNE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$73.53 M
-$10.24 M-12.22%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly total current assets is $73.53 million, with the most recent change of -$10.24 million (-12.22%) on September 30, 2024.
- Over the past year, VYNE quarterly current assets has dropped by -$10.24 million (-12.22%).
- VYNE quarterly current assets is now -53.94% below its all-time high of $159.66 million, reached on March 31, 2018.
Performance
VYNE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
VYNE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +150.7% | -12.2% |
| 3 y3 years | +10.0% | +92.1% |
| 5 y5 years | -31.2% | +92.1% |
VYNE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +150.7% | -23.4% | +319.9% |
| 5 y | 5-year | at high | +150.7% | -48.6% | +319.9% |
| alltime | all time | -31.2% | +204.3% | -53.9% | +319.9% |
VYNE Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.53 M(-12.2%) |
| Jun 2024 | - | $83.78 M(-7.1%) |
| Mar 2024 | - | $90.22 M(-6.0%) |
| Dec 2023 | $1.72 M(-30.6%) | $95.96 M(+448.0%) |
| Sep 2023 | - | $17.51 M(-23.7%) |
| Jun 2023 | - | $22.96 M(-30.5%) |
| Mar 2023 | - | $33.02 M(-13.7%) |
| Dec 2022 | $2.48 M(-35.7%) | $38.27 M(-13.1%) |
| Sep 2022 | - | $44.05 M(-15.2%) |
| Jun 2022 | - | $51.92 M(-14.4%) |
| Mar 2022 | - | $60.65 M(-4.0%) |
| Dec 2021 | $3.86 M(-40.5%) | $63.19 M(-17.0%) |
| Sep 2021 | - | $76.13 M(-40.7%) |
| Jun 2021 | - | $128.43 M(-10.3%) |
| Mar 2021 | - | $143.12 M(+64.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $6.48 M(+670.0%) | $87.26 M(-11.1%) |
| Sep 2020 | - | $98.16 M(-17.7%) |
| Jun 2020 | - | $119.29 M(+21.2%) |
| Mar 2020 | - | $98.44 M(+25.7%) |
| Dec 2019 | $842.00 K(+96.7%) | $78.33 M(-16.2%) |
| Sep 2019 | - | $93.43 M(-17.4%) |
| Jun 2019 | - | $113.13 M(-9.7%) |
| Mar 2019 | - | $125.22 M(-10.2%) |
| Dec 2018 | $428.00 K(-85.8%) | $139.50 M(-9.7%) |
| Sep 2018 | - | $154.47 M(-1.1%) |
| Jun 2018 | - | $156.16 M(-2.2%) |
| Mar 2018 | - | $159.66 M(+150.0%) |
| Dec 2017 | $3.01 M(-71.4%) | $63.86 M(-15.7%) |
| Sep 2017 | - | $75.78 M(+140.3%) |
| Dec 2016 | $10.51 M(>+9900.0%) | $31.54 M |
| Dec 2015 | $0.00 | - |
FAQ
- What is VYNE Therapeutics annual total current assets?
- What is the all time high annual current assets for VYNE Therapeutics?
- What is VYNE Therapeutics annual current assets year-on-year change?
- What is VYNE Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly current assets year-on-year change?
What is VYNE Therapeutics annual total current assets?
The current annual current assets of VYNE is $95.96 M
What is the all time high annual current assets for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total current assets is $139.50 M
What is VYNE Therapeutics annual current assets year-on-year change?
Over the past year, VYNE annual total current assets has changed by +$57.69 M (+150.72%)
What is VYNE Therapeutics quarterly total current assets?
The current quarterly current assets of VYNE is $73.53 M
What is the all time high quarterly current assets for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total current assets is $159.66 M
What is VYNE Therapeutics quarterly current assets year-on-year change?
Over the past year, VYNE quarterly total current assets has changed by -$10.24 M (-12.22%)